These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30833048)

  • 1. Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?
    Vaillant A
    Lancet Infect Dis; 2019 Mar; 19(3):221-222. PubMed ID: 30833048
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protocol for the antiviral therapy of hepatitis B and D].
    ; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
    Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
    Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
    Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New trend in treatment in patients with chronic hepatitis C].
    Werling K; Tulassay Z
    Orv Hetil; 2006 Apr; 147(14):637-41. PubMed ID: 16711370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels.
    Brillanti S; Levantesi F; Nigro G; Vicari S; Roda E
    Ann Intern Med; 2003 Dec; 139(11):W83. PubMed ID: 14644911
    [No Abstract]   [Full Text] [Related]  

  • 7. The good and evil of flare: flares in hepatitis B virus chronic hepatitis.
    Massetto B; Menzaghi B; Giambelli C; Antinori S; Milazzo L
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):821-3. PubMed ID: 17700272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
    de Niet A; Jansen L; Stelma F; Willemse SB; Kuiken SD; Weijer S; van Nieuwkerk CMJ; Zaaijer HL; Molenkamp R; Takkenberg RB; Koot M; Verheij J; Beuers U; Reesink HW
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):576-584. PubMed ID: 28522204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.
    Abbas Z; Yakoob J; Umer MA; Abbas M; Hamid S
    Antivir Ther; 2015; 20(5):529-33. PubMed ID: 25668821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
    Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus with normal transaminase levels.
    Puoti C
    Dig Dis; 2007; 25(3):277-8. PubMed ID: 17827956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
    Flink HJ; Sprengers D; Hansen BE; van Zonneveld M; de Man RA; Schalm SW; Janssen HL;
    Gut; 2005 Nov; 54(11):1604-9. PubMed ID: 15923670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis.
    Boettler T; Thimme R
    Dig Dis; 2015; 33(4):608-12. PubMed ID: 26159281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
    Dusheiko G; Danta M
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):130-1. PubMed ID: 16265150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic hepatitis C viral infection with persistent normal serum alanine aminotransferases].
    Huang CX; Bai XF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):70-1. PubMed ID: 15670508
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C.
    Lörke J; Erhardt A; Häussinger D
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):xx. PubMed ID: 15625645
    [No Abstract]   [Full Text] [Related]  

  • 18. The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.
    Hornberger J; Farci P; Prati D; Zeuzem S; Green J; Patel KK
    J Viral Hepat; 2006 Jun; 13(6):377-86. PubMed ID: 16842440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.